Welcome to LookChem.com Sign In|Join Free

CAS

  • or

46006-36-4

Post Buying Request

46006-36-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

46006-36-4 Usage

General Description

1H-Benzoimidazole-4-carboxylic acid is a chemical compound with the molecular formula C8H6N2O2. It is an aromatic heterocyclic compound consisting of a benzene ring fused to an imidazole ring, with a carboxylic acid functional group attached at position 4. 1H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID has potential applications in the pharmaceutical industry, specifically in the development of new drugs due to its structural properties and ability to interact with biological systems. Additionally, 1H-Benzoimidazole-4-carboxylic acid has been studied for its potential anti-inflammatory and antimicrobial properties, making it an interesting compound for further research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 46006-36-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,6,0,0 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 46006-36:
(7*4)+(6*6)+(5*0)+(4*0)+(3*6)+(2*3)+(1*6)=94
94 % 10 = 4
So 46006-36-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H6N2O2/c11-8(12)5-2-1-3-6-7(5)10-4-9-6/h1-4H,(H,9,10)(H,11,12)

46006-36-4Relevant articles and documents

MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

-

, (2018/03/25)

The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).

OXADIAZOLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF

-

Paragraph 0257; 0258-0260, (2017/02/02)

PROBLEM TO BE SOLVED: To provide therapeutic or preventive agents for various diseases or symptoms associated with a serotonin 4 receptor (particularly, neuropsychiatric diseases such as Alzheimer-type dementia). SOLUTION: The present invention provides a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. In the formula (1), Het represents formula (Het-1) or the like, A represents formula (A-1) or the like, B represents (B-1) or the like, R1A represents a hydrogen atom, an alkyl group or the like, R2A, R5, R6 and R7 represent a hydrogen atom, a halogen atom, an alkyl group or the like, R8 and R9 represent a hydrogen atom, an alkyl group or the like, and l represents an integer of 0-4. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

A facile one-pot synthesis of benzimidazoles from 2-nitroanilines by reductive cyclization

Liu, Zheng,Li, Haihong,Zhao, Qingjie,Shen, Jingshan

scheme or table, p. 1907 - 1911 (2009/04/06)

A facile one-pot process to prepare benzimidazole derivatives is described. Reductive cyclization of a serial of 2-nitroanilines with orthoesters in the presence of Pd/C in methanol at room temperature, which is promoted by a catalytic amount of acetic acid, affords the corresponding benzimidazole derivatives in high yields.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 46006-36-4